"Blood pressure", "sports", "blood sugar"... The market for smart wearable devices with various labels related to health, running and chronic disease management, the competition is extremely hot, Jiu'an Ihealth, å’•å’š, Huawei glory, music 4 manufacturers The WeChat version of the product has landed on Jingdong and other sales platforms, and set off a new round of communication fever! At the same time, Nike, fruit shells, Samsung, Apple and other new products in the smart wearable device market, but also earned the attention of countless people.
The smart wearable device market can be carefully combed, but it is difficult to find medical device giants and multinational pharmaceutical companies. Bayer, Novo Nordisk, Medtronic, Pfizer, Novartis, etc., have been brave in the personal blood glucose meter market, or have been bravely moving forward in the field of chronic disease management, targeting the hottest smart wearable devices of the moment. Is the combination of chronic disease management and personal lifestyle the closest product, does this coincide with the ideas advocated by these pharmaceutical giants? Why are they indifferent to this?
Sesame seeds? How big is the market capacity of smart wearable devices?
Blood glucose meter and blood pressure meter are the closest and most convenient medical devices to smart wearable devices. However, for the Johnson & Johnson, Roche, Omron and other medical equipment companies that produce blood glucose meters, the smart wearable device market has not seen them actively involved. The shadow.
Perhaps this market capacity is too small, nothing to earn?
iResearch expects that the size of China's wearable market will grow from 2 billion yuan (about 320 million US dollars) in 2013 to 17 billion yuan (about 2.7 billion US dollars). Compare this data with the blood glucose meter market and see how.
In 2012, China's domestic blood glucose meter market was about 2.5 billion yuan (about 400 million US dollars), and Roche and Johnson & Johnson accounted for 60% to 65% of the market share (about 240 million to 260 million). According to the data, the sales of Johnson & Johnson and Roche blood glucose meters in 2012 are very close to those of the domestic smart wearable device market in 2013.
Xi'an XJeson Biotech Co., Ltd , https://www.xjesonbio.com